Bausch & Lomb obtains needed consents for six notes series

By Jennifer Chiou

New York, Sept. 29 - Bausch & Lomb Inc. said it received the required consents for its $84.334 million of 7 1/8% debentures due 2028, $133.195 million of 6.95% senior notes due 2007, $50 million of 5.90% senior notes due 2008, $155.902 million of 2004 senior convertible securities due 2023, $4.098 million of floating-rate convertible senior notes due 2023 and $0.421 million of 6.56% medium-term series B notes due 2026, according to an 8-K filing with the Securities and Exchange Commission.

The company said it now has until 5:30 p.m. ET on Jan. 31 to file financial reports with the SEC.

The Rochester, N.Y., eye health company previously obtained consents from holders of a majority of five notes series while the solicitation for the 7 1/8% notes had been extended to 5 p.m. ET on Sept. 28 from Sept. 27.

The company announced the consent solicitations on Sept. 20. It was seeking consents to amendments to the note indentures to waive certain events of default.

Bausch & Lomb said it will pay a consent fee of $1.00 per $1,000 principal amount of notes, plus an additional $1.00 per $1,000 principal amount for each month from the initial consent payment date to the earlier of the filing compliance date or Jan. 31, 2007.

Citigroup Global Markets Inc. is the solicitation agent.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.